Navigation Links
AMP president updates CDC committee on H1N1 testing
Date:9/2/2009

Atlanta, GASeptember 2-3, 2009 Dr. Jan Nowak, President of the Association for Molecular Pathology presented public comments today at the Clinical Laboratory Improvement Advisory Committee meeting. During the initial weeks of the pandemic H1N1 influenza outbreak, community based molecular pathology laboratories developed diagnostic tests capable of rapidly detecting and confirming suspected cases of pandemic flu. Dr. Nowak reported on the efforts to confirm suspected cases in the Chicago area and among the broader AMP membership and discussed the challenges encountered by the diagnostic community as well as the opportunities to improve access to high quality rapid diagnostic tests for pandemic influenza.

AMP members stand ready to help with surge capacity during a reemergence of pandemic influenza strain during this year's flu season. Last April, when the first reports of the novel H1N1 influenza strain began to appear, community molecular pathology laboratories were confronted with the task of providing timely, useful information to their clinicians about this new infectious agent. An informal survey of AMP member laboratories during the first week of the H1N1 episode showed that 93% of the 43 respondents had a molecular assay that could detect and distinguish Influenza Type A from Type B. Those laboratories had an aggregate test capacity of 3,000 to 4,000 specimens/day, and could expand their capacity to as much as 12,000 specimens/day within 30 days if needed. Thirty-six percent of the laboratories reported having the capability of distinguishing the novel H1N1 strain from seasonal H1 strains. During week one of the outbreak, those laboratories had an aggregate test capacity approaching 2,500 specimens/day, with a potential of nearly 8,000 specimens/day within 30 days.

AMP members are uniquely qualified to develop and validate rapid diagnostics to confirm clinical cases of pandemic flu.

Early in week one of the outbreak, the molecular laboratories in the Chicago area participated in a conference call with the Illinois Department of Public Health to exchange information about tests in use, testing capacity, confirmatory capabilities, etc. Within a week the community labs had sufficient information to know that available assays for influenza A were capable of detecting the novel H1N1 strain, and furthermore, that some assays were capable of specifically identifying the novel H1N1 subtype. This knowledge greatly reduced the number of specimens that needed to be confirmed by IDPH. By the end of week two of the outbreak, many labs had sufficient data from IDPH to validate their assays, and were asked to limit their submissions for IDPH confirmation. After four weeks, more cases of H1N1 had been diagnosed in community molecular diagnostic laboratories (790 cases) than by IDPH (698 cases).

Dr. Nowak shared his experience, "by the end of the first week of the H1N1 episode, our own laboratory had identified 39 cases of probable H1N1 infection, only a fraction of which had been corroborated by our state public health laboratory, and confirmed only sometime after day 8." The CDC tally for all of Illinois at the end that week was still only 3 cases confirmed, a number widely reported in the media, which greatly misinformed the public and the medical community of the true nature of the spread of this disease in Illinois.

With the President's Council of Advisors on Science and Technology warning that more than half of the US population will be infected with the H1N1 influenza virus this flu season, AMP encourages close collaboration between molecular diagnostics laboratories, CDC, and public health laboratories to ensure prompt diagnosis and timely surveillance of the outbreak. Dr. Nowak expressed his pride in his profession's role in the outbreak, "In the recent H1N1 outbreak, I believe the quality of laboratory testing has been outstanding, as has been the response of molecular diagnostics laboratories to this public health emergency."


'/>"/>

Contact: Mary Steele Williams
mwilliams@amp.org
301-634-7921
Association for Molecular Pathology
Source:Eurekalert

Related biology news :

1. Presidents of Iceland, Bangladesh to discuss global climate change in New Orleans
2. Beginning scientists receive presidential awards
3. President honors mentors of scientists and engineers
4. IEEE-USA commends president for asking Congress to double support for critical research
5. Presidents science adviser to address IEEE International Homeland Security Conference
6. New book tutors future presidents and public on science behind the headlines
7. The Science Coalitions 10 questions for the presidential debate
8. Haag honored with Presidential Early Career Scientists Award
9. Small changes can lead to big rewards, says ASN president
10. Press statement on new CDC MRSA study from SHEA president
11. Innerscope Research(R) Appoints Digital Leader, Andre Marquis, as Senior Vice President of Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/7/2017)... LAKE CITY , March 7, 2017   ... that help top global companies identify the best talent, ... as Chief Sales Officer (CSO) and Diana ... Kucer,s appointments round out a seasoned executive team poised to ... and beyond, building on a year of record bookings ...
(Date:3/2/2017)... 2, 2017 Who risk to be deprived ... the full report: https://www.reportbuyer.com/product/4313699/ WILL APPLE ... FIELD? Fingerprint sensors using capacitive technology represent a ... vendor Idex forecasts an increase of 360% of the ... of the fingerprint sensor market between 2014 and 2017 ...
(Date:2/28/2017)... News solutions for biometrics, bag drop and ... ... to 16 March, Materna will present its complete end-to-end passenger ... is a real benefit for passengers. To accelerate the whole ... touch point solutions to take passengers through the complete integrated ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... DUBLIN , March 27, 2017 ... access to a comprehensive library of reports on Valero ... the transportation fuels and petrochemical industries. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) ... is biofuel production to go green. Ethanol today, even though ...
(Date:3/27/2017)... March 27, 2017 DarioHealth Corp. (NASDAQ: DRIO), ... and big data solutions, today announced that it is ... option for U.S. consumers who want to have their ... has signed strategic alliance agreements with partners across the ... benefits, and if approved, will supply and bill the ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... report to their offering. ... This report analyzes the Global market for Human ... forecasts are provided for the period 2014 through 2022. Market data ... The report profiles 25 companies including many key and niche ...
(Date:3/24/2017)... 24, 2017 Agenus Inc. (NASDAQ: AGEN), an ... and cancer vaccines, today announced participation at the following ... William Blair and Maidstone Life Sciences conference "Cancer Immunotherapy ... New York, NY . Agenus will ... at 9:40 am: Robert B. Stein , M.D., ...
Breaking Biology Technology: